HMOX1 and type 1 diabetes mellitus: Nevertheless, the fact that SFN treatment also activated the expression of HO-1 in db/db mice supported the idea that the improvement of the anti-allodynic actions of DOR agonists produced by SFN might be also consequence of the induction of HO-1, as occurs in animals with peripheral inflammation or type 1 diabetes [12, 22].